The drugmaker said it will seek U.S. authorization for this age group soon.
A health worker extract the Pfizer COVID-19 vaccine form a vial. The company announced Monday that its COVID-19 vaccine works for children ages 5 to 11 following trials.said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon ― a key step toward beginning vaccinations for youngsters.
The kid dosage also proved safe, with similar or fewer temporary side effects ― such as sore arms, fever or achiness ― that teens experience, he said.Gruber said the companies aim to apply to the Food and Drug Administration by the end of the month for emergency use in this age group, followed shortly afterward with applications to European and British regulators., FDA chief Dr.
“I feel a great sense of urgency” in making the vaccine available to children under 12, Gruber said. “There’s pent-up demand for parents to be able to have their children returned to a normal life.”
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Pfizer says COVID-19 vaccine works in kids ages 5 to 11Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon -- a key step toward beginning vaccinations for youngsters. The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older.
Consulte Mais informação »
Pfizer says COVID-19 vaccine safe, effective for kids ages 5 to 11Pfizer and BioNTech released data saying its vaccine is safe and effective for kids 5-11.
Consulte Mais informação »
Pfizer COVID-19 vaccine works in younger children, drugmaker saysPfizer says its COVID-19 vaccine is safe and likely to work in younger children, and it's planning to ask for permission to use it in kids as young as 5
Consulte Mais informação »
Pfizer and BioNTech say COVID-19 vaccine safe and effective in children aged 5 to 11Pfizer Inc. undefined and German partner BioNTech SE undefined on Monday announced positive results in a Phase 2/3 trial of their COVID-19 vaccine in...
Consulte Mais informação »
Covid-19 vaccine for 5- to 11-year-olds is safe and shows 'robust' antibody response, Pfizer saysA Phase 2/3 trial of Pfizer/BioNTech's two-dose Covid-19 vaccine for children ages 5 to 11 showed it is safe and generated a 'robust' antibody response.
Consulte Mais informação »
Pfizer Prepares To Seek U.S., EU Approval For Its Covid Vaccine In Kids As Young As FiveI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Consulte Mais informação »